Target intelligence / Profile preview

mRNA decay activator protein ZFP36L1 (ZFP36L1)

Target
ZFP36L1
Molecular classification
RNA-binding protein, CCCH-type zinc finger protein, Post-transcriptional regulator, mRNA decay activator
01

Overview

ZFP36L1 (mRNA decay activator protein ZFP36L1) is an RNA-binding protein belonging to the ZFP36 (TTP/TIS11) family, characterized by two CCCH-type zinc finger motifs. It regulates gene expression post-transcriptionally by binding AU-rich elements (AREs) in the 3′ untranslated region of target mRNAs, recruiting cellular decay enzymes (CCR4-NOT deadenylase, decapping enzymes DCP1/DCP2, exoribonucleases XRN1, and the exosome) for mRNA destabilization and degradation. ZFP36L1 serves roles in inflammation, antiviral defense (notably against influenza A, JEV, and DENV), angiogenesis, cancer suppression, B cell and thymic development, and muscle differentiation. Its antiviral activity is mechanistically linked to binding and destabilizing viral RNAs, and translational repression of select viral proteins. Dysregulation or mutation of ZFP36L1 can contribute to pathogenesis in numerous diseases.

Other names
TIS11BBRF1ERF1BERG36RNF162BZFP36-like 1cMG1Butyrate response factor 1EGF-response factor 1TPA-induced sequence 11bZinc finger protein 36, C3H type-like 1Early response factor Berg36
02

Mechanism of action

Drugs or gene interventions targeting ZFP36L1 would be expected to modulate gene expression via: - Enhancement or inhibition of ARE-mediated mRNA decay - Translational repression of target mRNAs - Modulation of antiviral activity by affecting ZFP36L1's RNA-binding function

03

Biological functions

Post-transcriptional gene regulationmRNA decay and destabilizationTranslational repressionRegulation of immune responsesAntiviral activity (host defense)Regulation of cell proliferation, apoptosis, angiogenesis, myogenesis, senescence, and B cell development
04

Disease associations

Cancer (tumor suppressor, regulation of apoptosis and proliferation)InflammationOsteoarthritisInfectious disease (antiviral defense against influenza A, Japanese encephalitis virus, dengue virus)Other (pathogenesis in developmental and immune disorders)
05

Safety considerations

Therapeutic manipulation may risk: Off-target mRNA destabilization affecting cell viabilityUnintended immune suppression or activationImpaired antiviral defense if activity is reduced
06

Interacting drugs

No drugs directly targeting ZFP36L1 are approved or widely documented in clinical use; experimental modulation has occurred via gene therapy/siRNA, but not small molecules.
07

Biomarkers

Expression level of ZFP36L1 may be a biomarker for: Cellular response to viral infectionInflammatory stateCancer progression/prognosis

Beyond the preview

Go deeper on mRNA decay activator protein ZFP36L1 (ZFP36L1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mRNA decay activator protein ZFP36L1 (ZFP36L1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call